PubMed for id: 1653962420

Year	Number of Results
1995	1
1997	4
2021	5
2024	0

1

Associations of Single-Nucleotide Polymorphisms in Slovenian Patients with Acute Central Serous Chorioretinopathy.

Kiraly P, Zupan A, Matjašič A, Mekjavić PJ. Kiraly P, et al. Genes (Basel). 2021 Dec 25;13(1):55. doi: 10.3390/genes13010055. Genes (Basel). 2021. PMID: 35052395 Free PMC article.

2

Oxaliplatin resistance in colorectal cancer enhances TRAIL sensitivity via death receptor 4 upregulation and lipid raft localization.

Greenlee JD, Lopez-Cavestany M, Ortiz-Otero N, Liu K, Subramanian T, Cagir B, King MR. Greenlee JD, et al. Elife. 2021 Aug 3;10:e67750. doi: 10.7554/eLife.67750. Elife. 2021. PMID: 34342264 Free PMC article.

3

Genetic variations in tumor ecrosis factor related apoptosis-inducing ligand receptor-1 (TRAIL-R1) gene and the susceptibility to b-cell non-hodgkin lymphoma (B-NHL) in Egypt.

Khorshied M, Soliman N, Khorshid O, Bakr S. Khorshied M, et al. Cancer Biomark. 2021;32(4):451-458. doi: 10.3233/CBM-201786. Cancer Biomark. 2021. PMID: 34275891

4

Epigenetic Modification of Death Receptor Genes for TRAIL and TRAIL Resistance in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia.

Watanabe A, Miyake K, Akahane K, Goi K, Kagami K, Yagita H, Inukai T. Watanabe A, et al. Genes (Basel). 2021 Jun 5;12(6):864. doi: 10.3390/genes12060864. Genes (Basel). 2021. PMID: 34198757 Free PMC article.

5

Downregulation of death receptor 4 is tightly associated with positive response of EGFR mutant lung cancer to EGFR-targeted therapy and improved prognosis.

Zhang S, Chen Z, Shi P, Fan S, He Y, Wang Q, Li Y, Ramalingam SS, Owonikoko TK, Sun SY. Zhang S, et al. Theranostics. 2021 Feb 15;11(8):3964-3980. doi: 10.7150/thno.54824. eCollection 2021. Theranostics. 2021. PMID: 33664875 Free PMC article.

6

Characterization of two receptors for TRAIL.

Schneider P, Bodmer JL, Thome M, Hofmann K, Holler N, Tschopp J. Schneider P, et al. FEBS Lett. 1997 Oct 27;416(3):329-34. doi: 10.1016/s0014-5793(97)01231-3. FEBS Lett. 1997. PMID: 9373179 Free article.

7

Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL.

MacFarlane M, Ahmad M, Srinivasula SM, Fernandes-Alnemri T, Cohen GM, Alnemri ES. MacFarlane M, et al. J Biol Chem. 1997 Oct 10;272(41):25417-20. doi: 10.1074/jbc.272.41.25417. J Biol Chem. 1997. PMID: 9325248 Free article.

8

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG, Rauch CT. Walczak H, et al. EMBO J. 1997 Sep 1;16(17):5386-97. doi: 10.1093/emboj/16.17.5386. EMBO J. 1997. PMID: 9311998 Free PMC article.

9

The receptor for the cytotoxic ligand TRAIL.

Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM. Pan G, et al. Science. 1997 Apr 4;276(5309):111-3. doi: 10.1126/science.276.5309.111. Science. 1997. PMID: 9082980

10

HLA-DR polymorphism affects the interaction with CD4.

Fleury S, Thibodeau J, Croteau G, Labrecque N, Aronson HE, Cantin C, Long EO, Sékaly RP. Fleury S, et al. J Exp Med. 1995 Sep 1;182(3):733-41. doi: 10.1084/jem.182.3.733. J Exp Med. 1995. PMID: 7650480 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year